Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Burmeister

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Internal Medicine Journal|February 18, 2009
Lung cancer patients in Queensland suffer delays in receiving radiation therapy--but not as a result of distanceB H Burmeister, D D Zarate, E A Burmeister, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 14, 2008
Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagusB M Smithers, G C Couper, J M Thomas, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 14, 2004
Chemoradiation therapy is effective for the palliative treatment of malignant dysphagiaJ A Harvey, J R Bessell, E Beller, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2014
Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysisK Kumagai, I Rouvelas, J A Tsai, et al.
The Lancet. Oncology|September 1, 2005
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trialBryan H Burmeister, B Mark Smithers, Val Gebski, et al.
Journal of Surgical Oncology|May 29, 2018
Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagusEls Visser, David Edholm, B Mark Smithers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)David L Ball, Richard J Fisher, Bryan H Burmeister, et al.
Clinical and Translational Radiation Oncology|July 13, 2023
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trialIris Bartula, Anh D Tran, Anna K Nowak, et al.
Annals of Surgical Oncology|June 8, 2024
Randomized Trial of Postoperative Radiation Therapy After Wide Excision of Neurotropic Melanoma of the Head and Neck (RTN2 Trial 01.09)Mark B Pinkham, A Herschtal, A M Hong, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Internal Medicine Journal|February 18, 2009
Lung cancer patients in Queensland suffer delays in receiving radiation therapy--but not as a result of distanceB H Burmeister, D D Zarate, E A Burmeister, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 14, 2008
Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagusB M Smithers, G C Couper, J M Thomas, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 14, 2004
Chemoradiation therapy is effective for the palliative treatment of malignant dysphagiaJ A Harvey, J R Bessell, E Beller, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2014
Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysisK Kumagai, I Rouvelas, J A Tsai, et al.
The Lancet. Oncology|September 1, 2005
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trialBryan H Burmeister, B Mark Smithers, Val Gebski, et al.
Journal of Surgical Oncology|May 29, 2018
Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagusEls Visser, David Edholm, B Mark Smithers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)David L Ball, Richard J Fisher, Bryan H Burmeister, et al.
Clinical and Translational Radiation Oncology|July 13, 2023
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trialIris Bartula, Anh D Tran, Anna K Nowak, et al.
Annals of Surgical Oncology|June 8, 2024
Randomized Trial of Postoperative Radiation Therapy After Wide Excision of Neurotropic Melanoma of the Head and Neck (RTN2 Trial 01.09)Mark B Pinkham, A Herschtal, A M Hong, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
Pageof 8